These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 9972283)

  • 1. Glucagon-like peptide-1 activates the adenylyl cyclase system in rockfish enterocytes and brain membranes.
    Mommsen TP; Mojsov S
    Comp Biochem Physiol B Biochem Mol Biol; 1998 Sep; 121(1):49-56. PubMed ID: 9972283
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Type VIII adenylyl cyclase in rat beta cells: coincidence signal detector/generator for glucose and GLP-1.
    Delmeire D; Flamez D; Hinke SA; Cali JJ; Pipeleers D; Schuit F
    Diabetologia; 2003 Oct; 46(10):1383-93. PubMed ID: 13680124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glucagon-like peptide-1 increases cAMP but fails to augment contraction in adult rat cardiac myocytes.
    Vila Petroff MG; Egan JM; Wang X; Sollott SJ
    Circ Res; 2001 Aug; 89(5):445-52. PubMed ID: 11532906
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The recombinant rat glucagon-like peptide-1 receptor, expressed in an alpha-cell line, is coupled to adenylyl cyclase activation and intracellular calcium release.
    Dillon JS; Lu M; Bowen S; Homan LL
    Exp Clin Endocrinol Diabetes; 2005 Mar; 113(3):182-9. PubMed ID: 15789279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cooperative enhancement of insulinotropic action of GLP-1 by acetylcholine uncovers paradoxical inhibitory effect of beta cell muscarinic receptor activation on adenylate cyclase activity.
    Miguel JC; Abdel-Wahab YH; Green BD; Mathias PC; Flatt PR
    Biochem Pharmacol; 2003 Jan; 65(2):283-92. PubMed ID: 12504804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Localization of the domains involved in ligand binding and activation of the glucose-dependent insulinotropic polypeptide receptor.
    Gelling RW; Wheeler MB; Xue J; Gyomorey S; Nian C; Pederson RA; McIntosh CH
    Endocrinology; 1997 Jun; 138(6):2640-3. PubMed ID: 9165060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of human and rat glucagon-like peptide-1 receptors in the neurointermediate lobe: lack of coupling to either stimulation or inhibition of adenylyl cyclase.
    Satoh F; Beak SA; Small CJ; Falzon M; Ghatei MA; Bloom SR; Smith DM
    Endocrinology; 2000 Apr; 141(4):1301-9. PubMed ID: 10746632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impaired cyclic AMP response to stimuli in glucose-desensitized rat pancreatic islets.
    Laychock SG
    Mol Cell Endocrinol; 1995 Aug; 113(1):19-28. PubMed ID: 8674810
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression and functional activity of glucagon, glucagon-like peptide I, and glucose-dependent insulinotropic peptide receptors in rat pancreatic islet cells.
    Moens K; Heimberg H; Flamez D; Huypens P; Quartier E; Ling Z; Pipeleers D; Gremlich S; Thorens B; Schuit F
    Diabetes; 1996 Feb; 45(2):257-61. PubMed ID: 8549871
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Desensitization and phosphorylation of the glucagon-like peptide-1 (GLP-1) receptor by GLP-1 and 4-phorbol 12-myristate 13-acetate.
    Widmann C; Dolci W; Thorens B
    Mol Endocrinol; 1996 Jan; 10(1):62-75. PubMed ID: 8838146
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exendin-(9-39) is an inverse agonist of the murine glucagon-like peptide-1 receptor: implications for basal intracellular cyclic adenosine 3',5'-monophosphate levels and beta-cell glucose competence.
    Serre V; Dolci W; Schaerer E; Scrocchi L; Drucker D; Efrat S; Thorens B
    Endocrinology; 1998 Nov; 139(11):4448-54. PubMed ID: 9794451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional expression of the rat glucagon-like peptide-I receptor, evidence for coupling to both adenylyl cyclase and phospholipase-C.
    Wheeler MB; Lu M; Dillon JS; Leng XH; Chen C; Boyd AE
    Endocrinology; 1993 Jul; 133(1):57-62. PubMed ID: 8391428
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Point mutations in the first and third intracellular loops of the glucagon-like peptide-1 receptor alter intracellular signaling.
    Heller RS; Kieffer TJ; Habener JF
    Biochem Biophys Res Commun; 1996 Jun; 223(3):624-32. PubMed ID: 8687446
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic response of teleost hepatocytes to glucagon-like peptide and glucagon.
    Mommsen TP; Moon TW
    J Endocrinol; 1990 Jul; 126(1):109-18. PubMed ID: 2166124
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ligand-induced regulation of glucagon-like peptide-I receptor function and expression in insulin-secreting beta cells.
    Fehmann HC; Jiang J; Pitt D; Schweinfurth J; Göke B
    Pancreas; 1996 Oct; 13(3):273-82. PubMed ID: 8884849
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glucagon-like peptide-1 causes pancreatic duodenal homeobox-1 protein translocation from the cytoplasm to the nucleus of pancreatic beta-cells by a cyclic adenosine monophosphate/protein kinase A-dependent mechanism.
    Wang X; Zhou J; Doyle ME; Egan JM
    Endocrinology; 2001 May; 142(5):1820-7. PubMed ID: 11316746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutations to the third cytoplasmic domain of the glucagon-like peptide 1 (GLP-1) receptor can functionally uncouple GLP-1-stimulated insulin secretion in HIT-T15 cells.
    Salapatek AM; MacDonald PE; Gaisano HY; Wheeler MB
    Mol Endocrinol; 1999 Aug; 13(8):1305-17. PubMed ID: 10446905
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glucagon-like peptide-1 improves insulin and proinsulin binding on RINm5F cells and human monocytes.
    Ebinger M; Jehle DR; Fussgaenger RD; Fehmann HC; Jehle PM
    Am J Physiol Endocrinol Metab; 2000 Jul; 279(1):E88-94. PubMed ID: 10893327
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glucagon-like peptide-1 (GLP-1) and glucose metabolism in human myocytes.
    Luque MA; González N; Márquez L; Acitores A; Redondo A; Morales M; Valverde I; Villanueva-Peñacarrillo ML
    J Endocrinol; 2002 Jun; 173(3):465-73. PubMed ID: 12065236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glucagon-like peptide-1 induces a cAMP-dependent increase of [Na+]i associated with insulin secretion in pancreatic beta-cells.
    Miura Y; Matsui H
    Am J Physiol Endocrinol Metab; 2003 Nov; 285(5):E1001-9. PubMed ID: 14534075
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.